Kersual, N., Garambois, V., Chardès, T., Pouget, J., Salhi, I., Bascoul-Mollevi, C., . . . Navarro-Teulon, I. (2014). The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer: Validation using the mAb 12G4. MAbs.
Stile di citazione ChicagoKersual, Nathalie, et al. "The Human Müllerian Inhibiting Substance Type II Receptor As Immunotherapy Target for Ovarian Cancer: Validation Using the MAb 12G4." MAbs 2014.
Citazione MLAKersual, Nathalie, et al. "The Human Müllerian Inhibiting Substance Type II Receptor As Immunotherapy Target for Ovarian Cancer: Validation Using the MAb 12G4." MAbs 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.